🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles privately for source information, while also receiving discount codes.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with numerous of members share “before and after” photos, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to users injecting products of uncertain source.

Some experts said the demand for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Platform Response and Content Elimination

Based on TikTok, the platform has removed problematic content and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service safe and investing in enhancing compliance measures.

Digital Marketplace Operations

Investigations also discovered communities with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays channels with numerous of members, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or administering at residence.

After minutes of entering one group, a seller shared contact information, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.

Item Details and Costs

Inside these communities, posts display dark colored packages with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at home with purified liquid, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A representative for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering substances they can’t verify. Even if the research behind this drug is sound, these online products may not contain what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to possibly serious medical dangers”.